CXCL13-UTRN Fusion FISH Probe
The CXCL13-UTRN Fusion FISH Probe is used to confirm a fusion of the CXCL13 and UTRN genes. The fusion of the CXCL13 and UTRN genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
CXCL13-UTRN-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-RERE | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-REOR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-REGO | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-REGR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-REAQ | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-ORRE | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-OROR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-ORGO | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-ORAQ | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GORE | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GOOR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GOGO | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GOGR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GOAQ | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GRRE | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GROR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GRGO | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GRGR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-GRAQ | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-AQRE | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-AQOR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-AQGO | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-AQGR | 20 (40 μL) | 200 μL | ||
CXCL13-UTRN-20-AQAQ | 20 (40 μL) | 200 μL |
UTRN Gene Summary
This gene shares both structural and functional similarities with the dystrophin gene. It contains an actin-binding N-terminus, a triple coiled-coil repeat central region, and a C-terminus that consists of protein-protein interaction motifs which interact with dystroglycan protein components. The protein encoded by this gene is located at the neuromuscular synapse and myotendinous junctions, where it participates in post-synaptic membrane maintenance and acetylcholine receptor clustering. Mouse studies suggest that this gene may serve as a functional substitute for the dystrophin gene and therefore, may serve as a potential therapeutic alternative to muscular dystrophy which is caused by mutations in the dystrophin gene. Alternative splicing of the utrophin gene has been described; however, the full-length nature of these variants has not yet been determined. [provided by RefSeq, Jul 2008]
Gene Name: Utrophin
Chromosome: CHR6: 144612872 -145174170
Locus: 6q24.2
CXCL13 Gene Summary
B lymphocyte chemoattractant, independently cloned and named Angie, is an antimicrobial peptide and CXC chemokine strongly expressed in the follicles of the spleen, lymph nodes, and Peyer's patches. It preferentially promotes the migration of B lymphocytes (compared to T cells and macrophages), apparently by stimulating calcium influx into, and chemotaxis of, cells expressing Burkitt's lymphoma receptor 1 (BLR-1). It may therefore function in the homing of B lymphocytes to follicles. [provided by RefSeq, Oct 2014]
Gene Name: C-X-C Motif Chemokine Ligand 13
Chromosome: CHR4: 78432906 -78532988
Locus: 4q21.1
Gene Diseases
The CXCL13 UTRN Fusion has been associated with the following diseases:
Disease Name |
---|
Lung Squamous Cell Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|